VPTVentripoint Diagnostics Ltd.
0.1100CAD+5.00%Mkt Cap: 14.35M $P/E:

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical Syst…

Key Statistics

Company
Market Cap14.35M $
Enterprise Value14.49M $
Revenue (TTM)131.03K $
Gross Profit131.03K $
Net Income (TTM)-2.33M $
Revenue/Share0.0007 USD
Last Price0.1100 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA92281P2008
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-5.86
EV/Revenue110.60
P/S106.90
P/B-3.66
EPS (TTM)-0.02
EPS (Forward)
52W Range
0.080027% of range0.1900
52W High0.1900 CAD
52W Low0.0800 CAD
Profitability
Gross Margin100.00%
Oper. Margin-17160.90%
EBITDA Margin0.00%
Profit Margin-1778.62%
ROE77.74%
ROA-677.90%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-1.13M $
CapEx (TTM)
FCF Margin-883.54%
FCF Yield-8.07%
Net Debt1.86M $
Net Debt/EBITDA-0.75
Balance Sheet
Debt/Equity-0.63
Current Ratio0.08
Quick Ratio0.04
Book Value/Sh-0.0280 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateDec 7, 2015
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.187.66M
Float166.53M
Insiders1.62%
Institutions0.00%
Short Interest
Short Ratio2.0d
Short % Out.0.09%
Shares Short144.97K
Short (prev mo.)147.66K
Technical
SMA 500.1100 (-0.0%)
SMA 2000.1164 (-5.5%)
Beta0.04
S&P 52W Chg18.16%
Avg Vol (30d)106.64K
Avg Vol (10d)139.15K
Technical Indicators
RSI (14)47.8
MACD-0.0029
MACD Signal-0.0028
MACD Hist.-0.0001
BB Upper0.1180 CAD
BB Middle0.1070 CAD
BB Lower0.0960 CAD
BB Width20.48%
ATR (14)0.0058 CAD
Vol Ratio (20d)0.20x